An overview of regular dialysis treatment in Japan (as of 31 December 2013)

I Masakane, S Nakai, S Ogata, N Kimata… - Therapeutic …, 2015 - Wiley Online Library
A nationwide survey of 4325 dialysis facilities was conducted at the end of 2013, among
which 4268 (98.7%) responded. The number of new dialysis patients was 38 095 in 2013 …

Aging and chronic kidney disease

K Nitta, K Okada, M Yanai, S Takahashi - Kidney and Blood Pressure …, 2014 - karger.com
A recent report has dealt with geriatric nephrology, including epidemiology and
pathophysiology of chronic kidney disease (CKD), attempting to get nephrologists to pay …

Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality

K Nitta, S Goto, I Masakane, N Hanafusa… - Renal Replacement …, 2020 - Springer
The annual survey of the Japanese Society for Dialysis Therapy Renal Data Registry
(JRDR) was sent to 4458 dialysis facilities at the end of 2018; among these facilities, 4402 …

Sex-specific differences in hemodialysis prevalence and practices and the male-to-female mortality rate: the Dialysis Outcomes and Practice Patterns Study (DOPPS)

M Hecking, BA Bieber, J Ethier, A Kautzky-Willer… - PLoS …, 2014 - journals.plos.org
Background A comprehensive analysis of sex-specific differences in the characteristics,
treatment, and outcomes of individuals with end-stage renal disease undergoing dialysis …

[HTML][HTML] Hypomagnesemia is a significant predictor of cardiovascular and non-cardiovascular mortality in patients undergoing hemodialysis

Y Sakaguchi, N Fujii, T Shoji, T Hayashi, H Rakugi… - Kidney international, 2014 - Elsevier
Although previous studies in the general population showed that hypomagnesemia is a risk
for cardiovascular diseases (CVD), the impact of magnesium on the prognosis of patients on …

Spironolactone reduces cardiovascular and cerebrovascular morbidity and mortality in hemodialysis patients

Y Matsumoto, Y Mori, S Kageyama, K Arihara… - Journal of the American …, 2014 - jacc.org
Objectives: This study sought to assess whether spironolactone treatment reduces the high
incidence of cardiovascular and cerebrovascular (CCV) morbidity and mortality in …

Annual dialysis data report 2015, JSDT renal data registry

I Masakane, M Taniguchi, S Nakai, K Tsuchida… - Renal Replacement …, 2018 - Springer
The annual survey of Japanese Society for Dialysis Therapy Renal Data Registry (JRDR)
was conducted for 4380 dialysis facilities at the end of 2015, among which 4321 facilities …

Effect of treating hyperphosphatemia with lanthanum carbonate vs calcium carbonate on cardiovascular events in patients with chronic kidney disease undergoing …

H Ogata, M Fukagawa, H Hirakata, T Kagimura… - Jama, 2021 - jamanetwork.com
Importance Among patients with hyperphosphatemia undergoing dialysis, it is unclear
whether non–calcium-based phosphate binders are more effective than calcium-based …

Annual dialysis data report 2017, JSDT renal data registry

K Nitta, I Masakane, N Hanafusa, M Taniguchi… - Renal Replacement …, 2019 - Springer
The annual survey of the Japanese Society for Dialysis Therapy Renal Data Registry
(JRDR) was conducted for 4413 dialysis facilities at the end of 2017; among which 4360 …

Pruritus in hemodialysis patients: Results from the J apanese D ialysis O utcomes and P ractice P atterns S tudy (JDOPPS)

N Kimata, DS Fuller, A Saito, T Akizawa… - Hemodialysis …, 2014 - Wiley Online Library
Pruritus affects many patients undergoing hemodialysis (HD). In this study, pruritus and its
relationship to morbidity, quality of life (QoL), sleep quality, and patient laboratory measures …